Tokyo Medical University
Welcome,         Profile    Billing    Logout  
 6 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Itoi, Takao
PASSAGE, NCT05644951: Clinical Trial of EPASS with Hot AXIOS System

Active, not recruiting
N/A
51
Japan
Hot AXIOS system used for EPASS
Boston Scientific Corporation
Gastric Outlet Obstruction
12/24
03/25
Nagakawa, Yuichi
ENSEMBLE, NCT05646511: TNT of SCRT+CAPOX Vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer

Recruiting
3
608
Japan
SCRT, Active Comparator & Experimental, CAPOX, Active Comparator, CAPOXIRI, Experimental
National Cancer Center Hospital East, Japan Agency for Medical Research and Development
Locally Advanced Rectal Cancer
12/29
12/30
Tanaka, Nobuhiro
EMPA-AHF, NCT05392764: Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

Recruiting
3
524
Japan
Empagliflozin 10 MG, Placebo
Juntendo University, Boehringer Ingelheim
Acute Heart Failure
03/25
12/27
POST-PCI FLOW, NCT04684043: Prognostic Implications of Physiologic Investigation After Revascularization With Stent

Recruiting
N/A
5100
RoW
Percutaneous coronary intervention
Bon-Kwon Koo, Inje University Ilsan Paik Hospital, Goyang, South Korea, Nanjing First Hospital, Nanjing Medical University, Nanjing, China, Tsuchiura Kyodo General Hospital, Ibaraki, Japan, McGovern Medical School at UTHealth and Memorial Hermann Hospital, TX, USA, Nagoya City University Graduate School of Medical Science, Nagoya, Japan, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium, San Raffaele Scientific Institute, Milan, Italy, Ajou University Hospital, Suwon, South Korea, University of Cincinnati, Cincinnati, OH, USA, Kyoto Second Red Cross Hospital, Kyoto, Japan, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
Coronary Disease
02/21
02/21
Kobayashi, Masatake
EMPA-AHF, NCT05392764: Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

Recruiting
3
524
Japan
Empagliflozin 10 MG, Placebo
Juntendo University, Boehringer Ingelheim
Acute Heart Failure
03/25
12/27

Download Options